Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients.

Mannino GC, Pezzilli S, Averta C, Fuoco A, Spiga R, Mancuso E, Di Fatta C, Perticone F, Prudente S, Trischitta V, Andreozzi F, Sesti G.

Cardiovasc Diabetol. 2019 Aug 13;18(1):102. doi: 10.1186/s12933-019-0906-1.

2.

Fine-scale haplotype mapping of MUT, AACS, SLC6A15 and PRKCA genes indicates association with insulin resistance of metabolic syndrome and relationship with branched chain amino acid metabolism or regulation.

Haydar S, Grigorescu F, Vintilă M, Cogne Y, Lautier C, Tutuncu Y, Brun JF, Robine JM, Pugeat M, Normand C, Poucheret P, Gheorghiu ML, Georgescu C, Badiu C, Băculescu N, Renard E, Ylli D, Badiou S, Sutra T, Cristol JP, Mercier J, Gomis R, Macias JM, Litvinov S, Khusnutdinova E, Poiana C, Pasquali R, Lauro D, Sesti G, Prudente S, Trischitta V, Tsatsoulis A, Abdelhak S, Barakat A, Zenati A, Ylli A, Satman I, Kanninen T, Rinato Y, Missoni S.

PLoS One. 2019 Mar 26;14(3):e0214122. doi: 10.1371/journal.pone.0214122. eCollection 2019.

3.

Genetic characterization of suspected MODY patients in Tunisia by targeted next-generation sequencing.

Dallali H, Pezzilli S, Hechmi M, Sallem OK, Elouej S, Jmel H, Ben Halima Y, Chargui M, Gharbi M, Mercuri L, Alberico F, Mazza T, Bahlous A, Ben Ahmed M, Jamoussi H, Abid A, Trischitta V, Abdelhak S, Prudente S, Kefi R.

Acta Diabetol. 2019 May;56(5):515-523. doi: 10.1007/s00592-018-01283-5. Epub 2019 Jan 17.

PMID:
30656436
4.

Variability in genes regulating vitamin D metabolism is associated with vitamin D levels in type 2 diabetes.

Bertoccini L, Bailetti D; SUMMER Study in Diabetes Group, Buzzetti R, Cavallo MG, Copetti M, Cossu E, D'Angelo P, De Cosmo S, Di Mauro L, Leonetti F, Morano S, Morviducci L, Napoli N, Prudente S, Pugliese G, Trischitta V, Baroni MG.

Oncotarget. 2018 Oct 9;9(79):34911-34918. doi: 10.18632/oncotarget.26178. eCollection 2018 Oct 9.

5.

Familial diabetes of adulthood: A bin of ignorance that needs to be addressed.

Prudente S, Ludovico O, Trischitta V.

Nutr Metab Cardiovasc Dis. 2017 Dec;27(12):1053-1059. doi: 10.1016/j.numecd.2017.10.017. Epub 2017 Oct 26. Review.

PMID:
29174219
6.

Insights From Molecular Characterization of Adult Patients of Families With Multigenerational Diabetes.

Pezzilli S, Ludovico O, Biagini T, Mercuri L, Alberico F, Lauricella E, Dallali H, Capocefalo D, Carella M, Miccinilli E, Piscitelli P, Scarale MG, Mazza T, Trischitta V, Prudente S.

Diabetes. 2018 Jan;67(1):137-145. doi: 10.2337/db17-0867. Epub 2017 Oct 9.

7.

Some Doubts About the Mantra on the Deleterious Cardiovascular Effects of Sulfonylureas.

Trischitta V, Prudente S.

Diabetes. 2017 Aug;66(8):2069-2071. doi: 10.2337/dbi17-0023. No abstract available.

8.

Pharmacogenetics of oral antidiabetes drugs: evidence for diverse signals at the IRS1 locus.

Prudente S, Di Paola R, Pezzilli S, Garofolo M, Lamacchia O, Filardi T, Mannino GC, Mercuri L, Alberico F, Scarale MG, Sesti G, Morano S, Penno G, Cignarelli M, Copetti M, Trischitta V.

Pharmacogenomics J. 2018 May 22;18(3):431-435. doi: 10.1038/tpj.2017.32. Epub 2017 Jul 11.

PMID:
28696414
9.

Unusual association of SCN2A epileptic encephalopathy with severe cortical dysplasia detected by prenatal MRI.

Bernardo S, Marchionni E, Prudente S, De Liso P, Spalice A, Giancotti A, Manganaro L, Pizzuti A.

Eur J Paediatr Neurol. 2017 May;21(3):587-590. doi: 10.1016/j.ejpn.2017.01.014. Epub 2017 Feb 7.

PMID:
28254201
10.

Clinical worthlessness of genetic prediction of common forms of diabetes mellitus and related chronic complications: A position statement of the Italian Society of Diabetology.

Buzzetti R, Prudente S, Copetti M, Dauriz M, Zampetti S, Garofolo M, Penno G, Trischitta V.

Nutr Metab Cardiovasc Dis. 2017 Feb;27(2):99-114. doi: 10.1016/j.numecd.2016.08.005. Epub 2016 Aug 26. Review.

PMID:
28063875
11.

The PPARγ2 P12A polymorphism is not associated with all-cause mortality in patients with type 2 diabetes mellitus.

Pacilli A, Prudente S, Copetti M, Fontana A, Mercuri L, Bacci S, Marucci A, Alberico F, Viti R, Palena A, Lamacchia O, Cignarelli M, De Cosmo S, Trischitta V.

Endocrine. 2016 Oct;54(1):38-46. Epub 2016 Mar 8.

PMID:
26956846
12.

The rs12917707 polymorphism at the UMOD locus and glomerular filtration rate in individuals with type 2 diabetes: evidence of heterogeneity across two different European populations.

Prudente S, Di Paola R, Copetti M, Lucchesi D, Lamacchia O, Pezzilli S, Mercuri L, Alberico F, Giusti L, Garofolo M, Penno G, Cignarelli M, De Cosmo S, Trischitta V.

Nephrol Dial Transplant. 2017 Oct 1;32(10):1718-1722. doi: 10.1093/ndt/gfw262.

PMID:
27448670
13.

The "Sapienza University Mortality and Morbidity Event Rate (SUMMER) study in diabetes": Study protocol.

Barchetta I, Capoccia D, Baroni MG, Buzzetti R, Cavallo MG, De Cosmo S, Leonetti F, Leotta S, Morano S, Morviducci L, Prudente S, Pugliese G, Trischitta V; SUMMER Study in Diabetes Group.

Nutr Metab Cardiovasc Dis. 2016 Feb;26(2):103-8. doi: 10.1016/j.numecd.2015.09.009. Epub 2015 Oct 9.

PMID:
26698225
14.

A genetic marker of hyperuricemia predicts cardiovascular events in a meta-analysis of three cohort studies in high risk patients.

Testa A, Prudente S, Leonardis D, Spoto B, Sanguedolce MC, Parlongo RM, Tripepi G, Rizza S, Mallamaci F, Federici M, Trischitta V, Zoccali C.

Nutr Metab Cardiovasc Dis. 2015 Dec;25(12):1087-94. doi: 10.1016/j.numecd.2015.08.004. Epub 2015 Aug 21. Review.

PMID:
26607700
15.

The TRIB3 Q84R polymorphism, insulin resistance and related metabolic alterations.

Prudente S, Trischitta V.

Biochem Soc Trans. 2015 Oct;43(5):1108-11. doi: 10.1042/BST20150115. Review.

PMID:
26517932
16.

Identification and Clinical Characterization of Adult Patients with Multigenerational Diabetes Mellitus.

Ludovico O, Carella M, Bisceglia L, Basile G, Mastroianno S, Palena A, De Cosmo S, Copetti M, Prudente S, Trischitta V.

PLoS One. 2015 Aug 19;10(8):e0135855. doi: 10.1371/journal.pone.0135855. eCollection 2015.

17.

Infrequent TRIB3 coding variants and coronary artery disease in type 2 diabetes.

Prudente S, Bailetti D, Mendonca C, Mannino GC, Fontana A, Andreozzi F, Hastings T, Mercuri L, Alberico F, Basile G, Copetti M, Sesti G, Doria A, Trischitta V.

Atherosclerosis. 2015 Sep;242(1):334-9. doi: 10.1016/j.atherosclerosis.2015.07.030. Epub 2015 Jul 17.

18.

Loss-of-Function Mutations in APPL1 in Familial Diabetes Mellitus.

Prudente S, Jungtrakoon P, Marucci A, Ludovico O, Buranasupkajorn P, Mazza T, Hastings T, Milano T, Morini E, Mercuri L, Bailetti D, Mendonca C, Alberico F, Basile G, Romani M, Miccinilli E, Pizzuti A, Carella M, Barbetti F, Pascarella S, Marchetti P, Trischitta V, Di Paola R, Doria A.

Am J Hum Genet. 2015 Jul 2;97(1):177-85. doi: 10.1016/j.ajhg.2015.05.011. Epub 2015 Jun 11.

19.

Mutations Impairing GSK3-Mediated MAF Phosphorylation Cause Cataract, Deafness, Intellectual Disability, Seizures, and a Down Syndrome-like Facies.

Niceta M, Stellacci E, Gripp KW, Zampino G, Kousi M, Anselmi M, Traversa A, Ciolfi A, Stabley D, Bruselles A, Caputo V, Cecchetti S, Prudente S, Fiorenza MT, Boitani C, Philip N, Niyazov D, Leoni C, Nakane T, Keppler-Noreuil K, Braddock SR, Gillessen-Kaesbach G, Palleschi A, Campeau PM, Lee BH, Pouponnot C, Stella L, Bocchinfuso G, Katsanis N, Sol-Church K, Tartaglia M.

Am J Hum Genet. 2015 May 7;96(5):816-25. doi: 10.1016/j.ajhg.2015.03.001. Epub 2015 Apr 9.

20.

Genetic Variant at the GLUL Locus Predicts All-Cause Mortality in Patients With Type 2 Diabetes.

Prudente S, Shah H, Bailetti D, Pezzolesi M, Buranasupkajorn P, Mercuri L, Mendonca C, De Cosmo S, Niewczas M, Trischitta V, Doria A.

Diabetes. 2015 Jul;64(7):2658-63. doi: 10.2337/db14-1653. Epub 2015 Feb 12.

21.

IRS1 G972R missense polymorphism is associated with failure to oral antidiabetes drugs in white patients with type 2 diabetes from Italy.

Prudente S, Morini E, Lucchesi D, Lamacchia O, Bailetti D, Mercuri L, Alberico F, Copetti M, Pucci L, Fariello S, Giusti L, Cignarelli M, Penno G, De Cosmo S, Trischitta V.

Diabetes. 2014 Sep;63(9):3135-40. doi: 10.2337/db13-1966. Epub 2014 Jun 19.

22.

The SH2B1 obesity locus and abnormal glucose homeostasis: lack of evidence for association from a meta-analysis in individuals of European ancestry.

Prudente S, Copetti M, Morini E, Mendonca C, Andreozzi F, Chandalia M, Baratta R; DIAGRAM consortium, Pellegrini F, Mercuri L, Bailetti D, Abate N, Frittitta L, Sesti G, Florez JC, Doria A, Trischitta V.

Nutr Metab Cardiovasc Dis. 2013 Nov;23(11):1043-9. doi: 10.1016/j.numecd.2013.05.001. Epub 2013 Oct 5.

PMID:
24103803
23.

The IRS1 G972R polymorphism and glomerular filtration rate in patients with type 2 diabetes of European ancestry.

De Cosmo S, Prudente S, Lamacchia O, Pucci L, Lucchesi D, Mendonca C, Bailetti D, Copetti M, Pellegrini F, Cignarelli M, Penno G, Doria A, Trischitta V.

Nephrol Dial Transplant. 2013 Dec;28(12):3031-4. doi: 10.1093/ndt/gft325. Epub 2013 Sep 26.

24.

Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes.

Qi L, Qi Q, Prudente S, Mendonca C, Andreozzi F, di Pietro N, Sturma M, Novelli V, Mannino GC, Formoso G, Gervino EV, Hauser TH, Muehlschlegel JD, Niewczas MA, Krolewski AS, Biolo G, Pandolfi A, Rimm E, Sesti G, Trischitta V, Hu F, Doria A.

JAMA. 2013 Aug 28;310(8):821-8. doi: 10.1001/jama.2013.276305.

25.

GALNT2 expression is reduced in patients with Type 2 diabetes: possible role of hyperglycemia.

Marucci A, di Mauro L, Menzaghi C, Prudente S, Mangiacotti D, Fini G, Lotti G, Trischitta V, Di Paola R.

PLoS One. 2013 Jul 22;8(7):e70159. doi: 10.1371/journal.pone.0070159. Print 2013.

26.

Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes.

Menzaghi C, Bacci S, Salvemini L, Mendonca C, Palladino G, Fontana A, De Bonis C, Marucci A, Goheen E, Prudente S, Morini E, Rizza S, Kanagaki A, Fini G, Mangiacotti D, Federici M, De Cosmo S, Pellegrini F, Doria A, Trischitta V.

PLoS One. 2013 Jun 3;8(6):e64729. doi: 10.1371/journal.pone.0064729. Print 2014.

27.

Joint effect of insulin signaling genes on insulin secretion and glucose homeostasis.

Prudente S, Morini E, Marselli L, Baratta R, Copetti M, Mendonca C, Andreozzi F, Chandalia M, Pellegrini F, Bailetti D, Alberico F, Shah H, Abate N, Sesti G, Frittitta L, Marchetti P, Doria A, Trischitta V.

J Clin Endocrinol Metab. 2013 Jun;98(6):E1143-7. doi: 10.1210/jc.2012-4282. Epub 2013 Apr 30.

28.

Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance.

Bacci S, Prudente S, Copetti M, Spoto B, Rizza S, Baratta R, Di Pietro N, Morini E, Di Paola R, Testa A, Mallamaci F, Tripepi G, Zhang YY, Mercuri L, Di Silvestre S, Lauro R, Malatino L, Consoli A, Pellegrini F, Pandolfi A, Frittitta L, Zoccali C, Federici M, Doria A, Trischitta V.

Atherosclerosis. 2013 Jan;226(1):140-5. doi: 10.1016/j.atherosclerosis.2012.10.035. Epub 2012 Oct 16.

29.

Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence.

De Cosmo S, Menzaghi C, Prudente S, Trischitta V.

Nephrol Dial Transplant. 2013 Jan;28(1):29-36. doi: 10.1093/ndt/gfs290. Epub 2012 Oct 9. Review.

PMID:
23048172
30.

Genetic prediction of common diseases. Still no help for the clinical diabetologist!

Prudente S, Dallapiccola B, Pellegrini F, Doria A, Trischitta V.

Nutr Metab Cardiovasc Dis. 2012 Nov;22(11):929-36. doi: 10.1016/j.numecd.2012.04.010. Epub 2012 Jul 21. Review.

31.

The 9p21 coronary artery disease locus and kidney dysfunction in patients with Type 2 diabetes mellitus.

De Cosmo S, Prudente S, Lamacchia O, Lucchesi D, Shah H, Mendonca C, Pucci L, Mercuri L, Gervino EV, Hauser TH, Bailetti D, Penno G, Cignarelli M, Doria A, Trischitta V.

Nephrol Dial Transplant. 2012 Dec;27(12):4411-3. doi: 10.1093/ndt/gfs148. Epub 2012 May 23.

32.

The mammalian tribbles homolog TRIB3, glucose homeostasis, and cardiovascular diseases.

Prudente S, Sesti G, Pandolfi A, Andreozzi F, Consoli A, Trischitta V.

Endocr Rev. 2012 Aug;33(4):526-46. doi: 10.1210/er.2011-1042. Epub 2012 May 10. Review.

33.

The ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) K121Q polymorphism modulates the beneficial effect of weight loss on fasting glucose in non-diabetic individuals.

Maranghi M, Prudente S, D'Erasmo L, Morini E, Ciociola E, Coletta P, Verrienti A, Arciello S, Copetti M, Pellegrini F, Santini SA, Morano S, Filetti S, Trischitta V.

Nutr Metab Cardiovasc Dis. 2013 Jun;23(6):505-10. doi: 10.1016/j.numecd.2011.11.003. Epub 2012 Mar 7.

PMID:
22402064
34.

ENPP1 mRNA levels in white blood cells and prediction of metformin efficacy in type 2 diabetic patients: a preliminary evidence.

Ludovico O, Farina MG, Copetti M, Palena A, Proto V, Marotta V, Strippoli GF, Frittitta L, Trischitta V, Prudente S.

Nutr Metab Cardiovasc Dis. 2012 Feb;22(2):e5-6. doi: 10.1016/j.numecd.2011.05.008. Epub 2011 Sep 14. No abstract available.

PMID:
21920717
35.

The SH2B1 obesity locus is associated with myocardial infarction in diabetic patients and with NO synthase activity in endothelial cells.

Prudente S, Morini E, Larmon J, Andreozzi F, Di Pietro N, Nigro A, Gervino EV, Mannino GC, Bacci S, Hauser TH, Bellacchio E, Formoso G, Pellegrini F, Proto V, Menzaghi C, Frittitta L, Pandolfi A, Sesti G, Doria A, Trischitta V.

Atherosclerosis. 2011 Dec;219(2):667-72. doi: 10.1016/j.atherosclerosis.2011.08.019. Epub 2011 Aug 19.

36.

ENPP1 affects insulin action and secretion: evidences from in vitro studies.

Di Paola R, Caporarello N, Marucci A, Dimatteo C, Iadicicco C, Del Guerra S, Prudente S, Sudano D, Miele C, Parrino C, Piro S, Beguinot F, Marchetti P, Trischitta V, Frittitta L.

PLoS One. 2011 May 5;6(5):e19462. doi: 10.1371/journal.pone.0019462.

37.

PPARγ2 P12A polymorphism and albuminuria in patients with type 2 diabetes: a meta-analysis of case-control studies.

De Cosmo S, Prudente S, Lamacchia O, Lapice E, Morini E, Di Paola R, Copetti M, Ruggenenti P, Remuzzi G, Vaccaro O, Cignarelli M, Trischitta V.

Nephrol Dial Transplant. 2011 Dec;26(12):4011-6. doi: 10.1093/ndt/gfr187. Epub 2011 Apr 14.

PMID:
21493814
38.

The type 2 diabetes and insulin-resistance locus near IRS1 is a determinant of HDL cholesterol and triglycerides levels among diabetic subjects.

Sharma R, Prudente S, Andreozzi F, Powers C, Mannino G, Bacci S, Gervino EV, Hauser TH, Succurro E, Mercuri L, Goheen EH, Shah H, Trischitta V, Sesti G, Doria A.

Atherosclerosis. 2011 May;216(1):157-60. doi: 10.1016/j.atherosclerosis.2011.01.022. Epub 2011 Jan 26.

39.

The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: evidence for interaction with obesity in diabetic patients.

Bacci S, Rizza S, Prudente S, Spoto B, Powers C, Facciorusso A, Pacilli A, Lauro D, Testa A, Zhang YY, Di Stolfo G, Mallamaci F, Tripepi G, Xu R, Mangiacotti D, Aucella F, Lauro R, Gervino EV, Hauser TH, Copetti M, De Cosmo S, Pellegrini F, Zoccali C, Federici M, Doria A, Trischitta V.

Diabetes. 2011 Mar;60(3):1000-7. doi: 10.2337/db10-1300. Epub 2011 Jan 31.

40.

The TRIB3 R84 variant is associated with increased carotid intima-media thickness in vivo and with enhanced MAPK signalling in human endothelial cells.

Formoso G, Di Tomo P, Andreozzi F, Succurro E, Di Silvestre S, Prudente S, Perticone F, Trischitta V, Sesti G, Pandolfi A, Consoli A.

Cardiovasc Res. 2011 Jan 1;89(1):184-92. doi: 10.1093/cvr/cvq255. Epub 2010 Aug 5.

PMID:
20693163
41.

TRIB3 R84 variant affects glucose homeostasis by altering the interplay between insulin sensitivity and secretion.

Prudente S, Baratta R, Andreozzi F, Morini E, Farina MG, Nigro A, Copetti M, Pellegrini F, Succurro E, Di Pietrantonio L, Brufani C, Barbetti F, Dallapiccola B, Sesti G, Trischitta V, Frittitta L.

Diabetologia. 2010 Jul;53(7):1354-61. doi: 10.1007/s00125-010-1749-1.

PMID:
20393693
42.

Insulin signaling regulating genes: effect on T2DM and cardiovascular risk.

Prudente S, Morini E, Trischitta V.

Nat Rev Endocrinol. 2009 Dec;5(12):682-93. doi: 10.1038/nrendo.2009.215. Review.

PMID:
19924153
43.

Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT.

De Cosmo S, Motterlini N, Prudente S, Pellegrini F, Trevisan R, Bossi A, Remuzzi G, Trischitta V, Ruggenenti P; BENEDICT Study Group.

Diabetes. 2009 Dec;58(12):2920-9. doi: 10.2337/db09-0407. Epub 2009 Aug 31.

44.

IRS1 G972R polymorphism and type 2 diabetes: a paradigm for the difficult ascertainment of the contribution to disease susceptibility of 'low-frequency-low-risk' variants.

Morini E, Prudente S, Succurro E, Chandalia M, Zhang YY, Mammarella S, Pellegrini F, Powers C, Proto V, Dallapiccola B, Cama A, Sesti G, Abate N, Doria A, Trischitta V.

Diabetologia. 2009 Sep;52(9):1852-7. doi: 10.1007/s00125-009-1426-4. Epub 2009 Jun 26.

45.

The emerging role of TRIB3 as a gene affecting human insulin resistance and related clinical outcomes.

Prudente S, Morini E, Trischitta V.

Acta Diabetol. 2009 Jun;46(2):79-84. doi: 10.1007/s00592-008-0087-y. Epub 2009 Jan 13. Review.

PMID:
19139803
46.

The TRIB3 Q84R polymorphism and risk of early-onset type 2 diabetes.

Prudente S, Scarpelli D, Chandalia M, Zhang YY, Morini E, Del Guerra S, Perticone F, Li R, Powers C, Andreozzi F, Marchetti P, Dallapiccola B, Abate N, Doria A, Sesti G, Trischitta V.

J Clin Endocrinol Metab. 2009 Jan;94(1):190-6. doi: 10.1210/jc.2008-1365. Epub 2008 Nov 4.

47.

Role of the ENPP1 K121Q polymorphism in glucose homeostasis.

Baratta R, Rossetti P, Prudente S, Barbetti F, Sudano D, Nigro A, Farina MG, Pellegrini F, Trischitta V, Frittitta L.

Diabetes. 2008 Dec;57(12):3360-4. doi: 10.2337/db07-1830. Epub 2008 Sep 5.

48.

TRIB3 R84 variant is associated with impaired insulin-mediated nitric oxide production in human endothelial cells.

Andreozzi F, Formoso G, Prudente S, Hribal ML, Pandolfi A, Bellacchio E, Di Silvestre S, Trischitta V, Consoli A, Sesti G.

Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1355-60. doi: 10.1161/ATVBAHA.108.162883. Epub 2008 Apr 24.

PMID:
18436806
49.

Interaction between PPARgamma2 variants and gender on the modulation of body weight.

Morini E, Tassi V, Capponi D, Ludovico O, Dallapiccola B, Trischitta V, Prudente S.

Obesity (Silver Spring). 2008 Jun;16(6):1467-70. doi: 10.1038/oby.2008.225. Epub 2008 Apr 3.

50.

A polymorphism at the IL6ST (gp130) locus is associated with traits of the metabolic syndrome.

Gottardo L, De Cosmo S, Zhang YY, Powers C, Prudente S, Marescotti MC, Trischitta V, Avogaro A, Doria A.

Obesity (Silver Spring). 2008 Jan;16(1):205-10. doi: 10.1038/oby.2007.28.

Supplemental Content

Loading ...
Support Center